Avalo Therapeutics, Inc. - COM NEW (AVTX)

Historical Institutional Holders from Q4 2023 to Q4 2024

All holders as of December 31, 2024
Q4 2024
Type / Class
Equity / COM NEW
Shares, excl. options Q4 2024
7.53M
Holdings value Q4 2024
$56M
Value change Q4 2024
+$4.83M
Grand Portfolio weight change Q4 2024
+0%
Number of holders
33
Number of buys Q4 2024
15
Number of sells Q4 2024
-8
Average buys Q4 2024 %
+0%
Average sells Q4 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q4 7.53M $56M +$4.83M $7.43 33
2024 Q3 6.66M $63.2M +$55.9M $9.50 28
2024 Q2 771K $9.62M +$8.43M $12.47 21
2024 Q1 87.5K $1.9M +$1.41M $21.75 18
2023 Q4 23K $209K +$209K $9.00 12